CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients.
Saved in:
| Title: | CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients. |
|---|---|
| Authors: | Arjuna S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2130 W. Holcombe Blvd., Suite 910, Houston, TX, 77030, USA., Pirhoushiaran M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2130 W. Holcombe Blvd., Suite 910, Houston, TX, 77030, USA., Bueno A; Department of Neurosurgery, McGovern Medical School at UT Health, Houston, TX, USA., Sanchez-Espitia A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2130 W. Holcombe Blvd., Suite 910, Houston, TX, 77030, USA., Tavakkol E; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, USA., Khalaj K; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, USA., Shah M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2130 W. Holcombe Blvd., Suite 910, Houston, TX, 77030, USA., Wang I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2130 W. Holcombe Blvd., Suite 910, Houston, TX, 77030, USA., Balar AP; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2130 W. Holcombe Blvd., Suite 910, Houston, TX, 77030, USA., Dono A; Department of Neurosurgery, McGovern Medical School at UT Health, Houston, TX, USA., Duose D; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2130 W. Holcombe Blvd., Suite 910, Houston, TX, 77030, USA., Nguyen S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2130 W. Holcombe Blvd., Suite 910, Houston, TX, 77030, USA., Kamali A; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, USA., Luthra R; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel CB; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Prabhu SS; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center Houston, Houston, TX, USA., Lang FF; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center Houston, Houston, TX, USA., Esquenazi Y; Department of Neurosurgery, McGovern Medical School at UT Health, Houston, TX, USA.; Memorial Hermann Hospital-TMC, Houston, TX, USA.; Center for Precision Health, McGovern Medical School, The University of Texas Health Science Center at Houston, 7000 Fannin St., Suite 600, Houston, TX, 77030, USA., Ballester LY; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. LYBallester1@mdanderson.org. |
| Source: | Journal of neuro-oncology [J Neurooncol] 2026 May 21; Vol. 178 (1). Date of Electronic Publication: 2026 May 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
